2025-07-20 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA), incorporating all the data you've provided.  The report is structured to first present key figures, then provide a more detailed analysis and finally a conclusion.

## Natera Inc. (NTRA) Analysis

**Ticker:** NTRA
**Company:** Natera Inc.
**Description:** Natera Inc. is a diagnostics company focused on cell-free DNA testing, primarily in the areas of reproductive health, oncology, and organ health.

### 1. Performance vs. S&P 500 (VOO)

*   **NTRA Cumulative Return:** 117.19%
*   **VOO Cumulative Return:** 97.02%
*   **Absolute Divergence:** 20.17%
*   **Relative Divergence:** 8.9 (on a scale where the min/max divergence range is considered 100)

**Analysis:** NTRA has outperformed the S&P 500 over the specified period. However, the relative divergence indicates that this outperformance is currently in the lower range of its historical variation compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha    | Beta   | Cap(B) |
|------------|---------|--------|----------|--------|--------|
| 2015-2017  | -6.0%   | 62.4%  | -31.0%   | 0.0    | 1.2    |
| 2016-2018  | 29.0%   | 80.1%  | 11.0%    | 0.0    | 1.9    |
| 2017-2019  | 159.0%  | 80.1%  | 130.0%   | 1.2    | 4.6    |
| 2018-2020  | 530.0%  | 80.1%  | 510.0%   | 0.3    | 13.6   |
| 2019-2021  | 355.0%  | 62.9%  | 307.0%   | 0.2    | 12.8   |
| 2020-2022  | -119.0% | 62.9%  | -121.0%  | 0.2    | 5.5    |
| 2021-2023  | -482.0% | 69.9%  | -500.0%  | 1.1    | 8.6    |
| 2022-2024  | -75.0%  | 70.6%  | -100.0%  | 1.2    | 21.6   |
| 2023-2025  | 66.0%   | 75.2%  | 17.0%    | 0.8    | 19.0   |

**Analysis:**

*   **CAGR:** Fluctuates significantly, indicating volatile growth periods.
*   **MDD:**  High Maximum Drawdown values point to substantial risk and price volatility.
*   **Alpha:**  Shows periods of significant outperformance (positive Alpha) and underperformance (negative Alpha) relative to the benchmark.  The large swings in Alpha highlight the stock's idiosyncratic risk.
*   **Beta:**  Generally low, suggesting that the stock is not highly correlated with the overall market. However, Beta values are unstable.
*   **Cap(B):**  Fluctuating market capitalization, reflecting periods of growth and decline.

### 2. Recent Price Action

*   **Current Price:** 138.90
*   **Previous Close:** 143.38
*   **Change:** -3.12
*   **5-Day Moving Average:** 147.74
*   **20-Day Moving Average:** 160.46
*   **60-Day Moving Average:** 158.87

**Analysis:**  The stock is currently trading below its 5, 20, and 60-day moving averages, suggesting a short-term downtrend. The price decrease from the previous close confirms this downward momentum.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3399 (Low Risk)
*   **RSI:** 16.47 (Oversold)
*   **PPO:** -1.79
*   **Hybrid Signal:** cash_70%_Sell 0.2% of holdings (1 shares - Caution - MRI:0.33) (Cash Ratio: 70% on 2025-07-03)
*   **Recent (20-day) Relative Divergence Change:** -1.5 (Negative - indicating a short-term decrease in relative performance)
*   **Expected Return:** 190.7% (Long-term, relative to S&P 500)

**Analysis:**

*   **RSI:** The extremely low RSI indicates the stock is heavily oversold and could be due for a rebound.
*   **MRI:** The low MRI suggests low overall market risk, which might mitigate some concerns about the specific stock.
*   **PPO:** Negative PPO indicates a downtrend in price momentum.
*   **Hybrid Signal:** The recommendation to reduce holdings and increase cash suggests a cautious outlook.
*   **Relative Divergence Change:** The negative change confirms the recent underperformance relative to the S&P 500.
*   **Price change:** the recent price change is significantly negative. This event impacts the analysis by reinforcing the bearish short-term outlook suggested by the moving averages and other indicators. It also highlights the volatility mentioned in the news headlines.
*   **Expected Return:** The very high expected return suggests strong potential for long-term growth, *if* the company's prospects materialize.  This is a speculative estimate.

### 4. Recent News & Significant Events

*   **Volatility:** The stock has exhibited notable volatility recently.
*   **Business Developments:** Major business developments, regulatory changes, or market events are influencing the stock.
*   **Analyst Discussions:** Analysts are actively discussing the company's performance and outlook.
*   **Risk & Opportunities:** Experts are highlighting both risks and opportunities for NTRA.

**Analysis:**  The news headlines reinforce the picture of a company experiencing significant events and fluctuating investor sentiment. Monitoring these developments is crucial for informed decision-making.

### 5. Recent Earnings Analysis

| 날짜         | EPS   | 매출       |
|--------------|-------|------------|
| 2025-05-09   | -0.5   | 0.50 B$    |
| 2024-11-12   | -0.26  | 0.44 B$    |
| 2024-08-09   | -0.3   | 0.41 B$    |
| 2024-05-10   | -0.56  | 0.37 B$    |
| 2025-05-09   | -0.56  | 0.37 B$    |

**Analysis:**

*   **EPS:** Natera is consistently reporting negative Earnings Per Share (EPS), indicating ongoing losses.
*   **Revenue:** Revenue shows a general upward trend, suggesting growth in sales, but not enough to offset losses.  The jump to 0.50B$ in the most recent quarter is encouraging.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-03-31 | $0.50B     | 63.12%        |
| 2024-12-31 | $0.48B     | 62.94%        |
| 2024-09-30 | $0.44B     | 61.79%        |
| 2024-06-30 | $0.41B     | 58.83%        |
| 2024-03-31 | $0.37B     | 56.72%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE        |
|------------|------------|------------|
| 2025-03-31 | $1.24B     | -5.40%     |
| 2024-12-31 | $1.20B     | -4.50%     |
| 2024-09-30 | $0.88B     | -3.60%     |
| 2024-06-30 | $0.84B     | -4.48%     |
| 2024-03-31 | $0.79B     | -8.51%     |

**Analysis:**

*   **Revenue:** Consistent quarter-over-quarter revenue growth is a positive sign.
*   **Profit Margin:** High and increasing profit margins are also a positive indicator of operational efficiency.
*   **Equity:** Equity has increased, suggesting financial strengthening.
*   **ROE:** Negative Return on Equity (ROE) reflects the ongoing losses despite revenue growth.

### 7. Overall Assessment

Natera Inc. (NTRA) presents a mixed picture.

*   **Positives:**
    *   Strong revenue growth and improving profit margins.
    *   High potential long-term return.
    *   Low market risk indicator (MRI).
*   **Negatives:**
    *   Consistent losses and negative ROE.
    *   High volatility and risk, as evidenced by large swings in Alpha and significant historical drawdowns.
    *   Recent price weakness and a negative short-term trend.
    *   Analyst caution and hybrid signal suggest reducing holdings.

**Conclusion:** NTRA appears to be a high-risk, high-reward investment.  The company is growing its revenue and improving its profit margins, but it's still not profitable.  The recent price weakness and negative technical indicators suggest caution in the short term.  Investors should carefully weigh the potential for long-term growth against the significant risks before investing in NTRA. Close monitoring of company news, earnings reports, and industry developments is essential.
